Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues

Roeland Zoutendijk, Milan Sonneveld, Jurriën Reijnders, Hanneke van Vuuren, Paula Biesta, Bettina Hansen, Andre Boonstra, HLA Janssen

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)322-327
Number of pages6
JournalJournal of Viral Hepatitis
Volume20
Issue number5
DOIs
Publication statusPublished - 2013

Cite this